05/04/2024 | Fulltime | Tulsa (Tulsa) | BioNTech SEBecome a member of the BioNTech Family! As a part of our team of more than 5.000 pioneers, you will play a key role in developing solutions for some of the most crucial scientific challenges of our age. Within less than a year, we were able to develop our COVID-19 mRNA vaccine following the highest
Save for later05/04/2024 | Fulltime | Tulsa (Tulsa) | BioNTech SEBecome a member of the BioNTech Family! As a part of our team of more than 5.000 pioneers, you will play a key role in developing solutions for some of the most crucial scientific challenges of our age. Within less than a year, we were able to develop our COVID-19 mRNA vaccine following the highest
Save for later05/04/2024 | Fulltime | Tulsa (Tulsa) | BioNTech SEBecome a member of the BioNTech Family! As a part of our team of more than 5.000 pioneers, you will play a key role in developing solutions for some of the most crucial scientific challenges of our age. Within less than a year, we were able to develop our COVID-19 mRNA vaccine following the highest
Save for later06/04/2024 | Fulltime | Chelmsford | RÜSCH AUSTRIA Gesellschaft m.b.H.And peripheral vascular diseases. We place a strategic emphasis on complex coronary and peripheral interventions, vascular access, bone access, specialty biologic treatments and cardiac assist. Our current Interventional products include a broad range of clinically relevant solutions, such as our GuideLiner
Save for later24/02/2024 | Fulltime | Chelmsford | RÜSCH AUSTRIA Gesellschaft m.b.H.And peripheral vascular diseases. We place a strategic emphasis on complex coronary and peripheral interventions, vascular access, bone access, specialty biologic treatments and cardiac assist. Our current Interventional products include a broad range of clinically relevant solutions, such as our GuideLiner
Save for later